Friday, April 27, 2018

Fat and Cancer

Over the past twenty plus years it has become more clear that obesity has a strong causative effect on the development of cancers. There is a multiplicity of reasons for this some of which are reasonably well documented while others are just logical connections. The path often follows the path: obesity, type 2 Diabetes, cancer. The first two steps can last for a long period while once the cancer starts it can be more aggressive than other non-obesity driven forms.

Countries as diverse as England and Ghana are suffering from mass obesity. Food, especially processed food is readily available and becoming quite inexpensive.

A recent note in NEJM by Abate-Shen, details the connection between fat and prostate cancer. This is a compelling presentation of data and well worth following. She notes:

Although most prostate cancers are relatively indolent and therefore not life-threatening, highly aggressive and metastatic disease develops in a subgroup of patients, and obesity has been associated with increased aggressiveness of prostate cancer. Chen et al. analyzed two key tumor-suppressor genes, PTEN and PML, that protect against prostate cancer. Tumor-suppressor genes promote cell functions that prevent cancer; therefore, their loss is often associated with accelerated development of cancer phenotypes. The loss of both PTEN and PML often occurs in the most aggressive forms of prostate cancer. Chen et al. investigated the functional consequences of the loss of PTEN and PML using mice that had been engineered to be deficient in these genes. They found that in mice deficient in Pten in the prostate, locally invasive prostate cancer developed, whereas in 30% of mice lacking both Pten and Pml, prostate cancer that metastasized to lymph nodes developed. These findings were interpreted to indicate that these genes work together to suppress a more aggressive prostate cancer phenotype. ...They found that among the top genes and biologic pathways affected were those involved in lipid production, a finding that suggests an association between fat production by the prostate cancer cells and an aggressive phenotype. In fact, they showed that the tumors that developed in the mice after the loss of Pten and Pml had high levels of key lipids in their cells. They also found evidence that increased lipid production is triggered by activation of the mitogen-activated protein kinase (MAPK) signaling pathway, which is frequently deregulated in prostate cancer. These findings led the investigators to consider whether fat may provide a cell-intrinsic signal to promote aggressive subtypes of prostate cancer by activating MAPK signaling. To test this idea, they fed the tumor-prone mice a high-fat diet and investigated whether more prevalent or more aggressive prostate cancer developed in these mice. The high-fat diet mimicked the effect of the loss of tumor-suppressor genes; in particular, the “obese” ... mice had a greater tendency toward the development of metastases, which occurred not only in lymph nodes but also in soft tissues such as the lung. Leveraging these findings, the authors then investigated whether fatostatin, a small-molecule inhibitor that targets a key regulator of fat production, could prevent metastasis. Indeed, the mice that were given fatostatin had less tumor growth and a lower incidence of metastasis than the control mice. Overall, these findings suggest that reducing levels of fat in prostate cells may improve outcomes of prostate cancer.

 Yes, fat is a driver, and a powerful one. Just think, many diseases could readily be prevented by just shutting one's mouth!